| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/15/2003 | EP1098901B1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 01/15/2003 | EP1023265B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/15/2003 | EP1009524B1 Improvements in or relating to capsules |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0880541B1 Derivatives of antibiotic ge2270 factors |
| 01/15/2003 | EP0815235B1 Vaccines for plague |
| 01/15/2003 | EP0713483B1 Amidine derivatives with nitric oxide synthetase activities |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | EP0584347B1 Enantiomeric hydroxylated xanthine compounds |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391609A Use of replication-deficient adenoviral vector to boost CD8+T cell immune response to antigen |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1391572A Oxazolidinones having sulfoximine functionality and their use as antimicrobial agents |
| 01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391556A IL-8 receptor antagonists |
| 01/15/2003 | CN1391487A Methods for treating therapy-resistant tumors |
| 01/15/2003 | CN1391483A Composition of octoxinol and polyvinyl chloride sorbitanate as accessory and uses in vaccins |
| 01/15/2003 | CN1391482A Therapy |
| 01/15/2003 | CN1391481A 疫苗 Vaccine |
| 01/15/2003 | CN1391479A Medicament for inducing tolerance |
| 01/15/2003 | CN1391478A Aqueous solution formulation of alpha-interferon |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1391472A Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 01/15/2003 | CN1391465A 包衣 Coating |
| 01/15/2003 | CN1391463A Intranasal influenza virus vaccine |
| 01/15/2003 | CN1390846A Aminoglycopeptide compounds with antivirus and anticanser activity |
| 01/15/2003 | CN1390836A Optical antimer of Saikexiaozuo and its preparing process and usage |
| 01/15/2003 | CN1390832A N,N'-diacetylcystine-arginine salt and its preparing process and usage |
| 01/15/2003 | CN1390577A Pill of tortoise plastron and turtle shell |
| 01/15/2003 | CN1390570A Liquid medicine for treating tinear |
| 01/15/2003 | CN1390554A Inflammation relieving paste |
| 01/15/2003 | CN1390550A Freeze-dried minocycline hydrochloride powder injection and its preparing process |
| 01/15/2003 | CN1390549A Medicine for treating beriberi |
| 01/15/2003 | CN1390546A Prescription of compound rifampin |
| 01/15/2003 | CN1390538A Slow-releasing Wannailuowei hydrochloride tablet and its preparing process |
| 01/15/2003 | CN1098849C 噻唑衍生物 Thiazole derivatives |
| 01/15/2003 | CN1098847C Furan-and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of replication of HIV-1 and HIV-1 mutants |
| 01/15/2003 | CN1098707C Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/15/2003 | CN1098694C Exterior-applied Chines medicine for treating aftos |
| 01/15/2003 | CN1098691C Propolis honey and its preparing process |
| 01/15/2003 | CN1098687C Use of aminopurine antiviral agents for treatment and prophylaxis of latent herpesvirus infections |
| 01/15/2003 | CN1098683C Application of scutellaria baicalensis glucoside as germicide for skin and mucosa |
| 01/14/2003 | US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment |
| 01/14/2003 | US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of |
| 01/14/2003 | US6506786 HIV protease inhibitors based on amino acid derivatives |
| 01/14/2003 | US6506783 A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide is disclosed. The particular fungicide used is a benzimidazole derivative |
| 01/14/2003 | US6506778 Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals |
| 01/14/2003 | US6506775 Substituted benzylaminopiperidine compounds |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |
| 01/14/2003 | US6506770 Antiviral compounds |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506751 Thiazolidinone compounds useful as chemokine inhibitors |
| 01/14/2003 | US6506740 Compounds that can be substituted at the 7, 8, and/or 9 positions and methods for preparing the 4- dedimethylamino tetracycline compounds. Other tetracycline compounds are the 4-dedimethylaminotetracycline derivatives with an oxime |
| 01/14/2003 | US6506726 Purification of an Echinocandin-type compound by adsorption onto a hydrophobic, reversed phase chromatographic media and eluting with a continuous nearly linear gradient of increasing acetic acid |
| 01/14/2003 | US6506591 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506581 Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| 01/14/2003 | US6506555 Use of HIV protease inhibiting compounds |
| 01/14/2003 | US6506406 Reduces smell of feces |
| 01/14/2003 | US6506385 Administering interferon, such as type I, to birds in ovo during last quarter of incubation; newcastle disease |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2114629C Receptor conjugates for targeting antibiotics to bacteria |
| 01/14/2003 | CA2114313C Bpc peptides, their preparation and use |
| 01/14/2003 | CA2086922C Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/09/2003 | WO2003003017A2 Use of transcription factor nak-1 or genes regulated by transcription factor nak-1 for the diagnosis and/or therapy of inflammatory and malignant diseases |
| 01/09/2003 | WO2003003004A2 Method for identifying compounds the specifically deplete mast cells |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002600A1 Use of soluble cytokeratine-1-fragments in diagnostics and therapy |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002580A1 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity |
| 01/09/2003 | WO2003002567A1 New pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections |
| 01/09/2003 | WO2003002565A1 2,6,9-substituted purine derivatives and their use n the treatment of proliferative disorders |
| 01/09/2003 | WO2003002560A1 New derivatives of oxazolidinones as antibacterial agents |
| 01/09/2003 | WO2003002558A1 Remedial agent for viral infectious disease |
| 01/09/2003 | WO2003002553A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002545A1 Peptoid compounds |
| 01/09/2003 | WO2003002544A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | WO2003002541A1 Pyridazinone |
| 01/09/2003 | WO2003002534A1 Bis-piperidines |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002522A1 Peptide deformylase inhibitors |
| 01/09/2003 | WO2003002152A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | WO2003002140A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 01/09/2003 | WO2003002132A1 Tea tree oil formulations |
| 01/09/2003 | WO2003002131A1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
| 01/09/2003 | WO2003002128A1 Methods and compositions for treatment of gastric diseases |
| 01/09/2003 | WO2003002127A1 Use of at least one glycoinhibitor substance |
| 01/09/2003 | WO2003002126A1 Anti-retroviral agent in combination with tea polyphenol for the treatment of viral infections |
| 01/09/2003 | WO2003002118A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/09/2003 | WO2003002069A2 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/09/2003 | WO2003002065A2 Hcv e1e2 vaccine compositions |
| 01/09/2003 | WO2003002064A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | WO2003001887A2 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | WO2003001881A2 Cell-based high-throughput screening methods |
| 01/09/2003 | WO2002080976A3 Hsa-free formulations of interferon-beta |